Search

everythinglearnresearchcommunity

for

Search:↓

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Mutations in the hairless gene cause hair loss and skin cysts in rhesus macaques.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

The research found specific genes that are more active in balding cells, which could be causing hair loss.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Potential therapeutic targets for scarring hair loss are identified.

Adipose-derived stem cells show promise in treatments but need more research for safety, especially in cancer.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Human epidermal neural crest stem cells could be used for therapies, drug discovery, and disease modeling.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Early attempts at using cloned cells for hair transplants failed, but 3D cell growth showed some promise.

Accurate fungal identification is crucial for proper treatment in immunocompromised patients.

CXCL12 can both help and harm hair growth in alopecia areata.

CCCA is a common, scarring hair loss in Black women that needs early detection.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Type 2 diabetic stem cells can still help heal wounds effectively.